Paul Ehrlich Institute / Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel (PEI)

Research facility


Location: Langen, Germany (DE) DE

ISNI: 0000000110190926

ROR: https://ror.org/00yssnc44

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Possible manufacture of test allergens in public pharmacies for the diagnosis of type I allergies: Legal aspects (2024) Jost R, Kespohl S, Paulus-Tremel KE, Zimmer J, Bonertz A, Sander I, Klose T, et al. Journal article, Review article Establishment of an ELISA-based in vitro test system to quantify the major honey bee venom allergen Api m 10 in crude bee venoms and therapy allergen products (2024) Landgraf A, Hein S, Paulus-Tremel KE, Wolff MB, Arend M, Junker AC, Strecker D, et al. Journal article IL-10-modulated dendritic cells from birch pollen- and hazelnut-allergic patients facilitate Treg-mediated allergen-specific and cross-reactive tolerance (2024) Heinl PV, Graulich E, Weigmann B, Wangorsch A, Ose R, Bellinghausen I, Khatri R, et al. Journal article Severely compromised supply of patch test allergens in Europe hampers adequate diagnosis of occupational and non-occupational contact allergy. A European Society of Contact Dermatitis (ESCD), European Academy of Allergy and Clinical Immunology (EAACI), European Academy of Dermatology and Venereology (EADV) task forces ‘Contact Dermatitis’ and ‘Occupational Skin Disease’ position paper (2024) John SM, Bonertz A, Zimmer J, Aerts O, Bauer A, Bova M, Brans R, et al. Journal article Controversy on health-based guidance values for bisphenol A—the need of criteria for studies that serve as a basis for risk assessment (2024) Leist M, Büttner A, Diel P, Eisenbrand G, Epe B, Först P, Grune T, et al. Journal article Correction to: Commentary of the SKLM to the EFSA opinion on risk assessment of N-nitrosamines in food (Archives of Toxicology, (2024), 98, 6, (1573-1580), 10.1007/s00204-024-03726-1) (2024) Eisenbrand G, Büttner A, Diel P, Epe B, Först P, Grune T, Haller D, et al. Journal article, Erratum Commentary of the SKLM to the EFSA opinion on risk assessment of N-nitrosamines in food (2024) Eisenbrand G, Büttner A, Diel P, Epe B, Först P, Grune T, Haller D, et al. Journal article Regulatory Issues of Platform Trials: Learnings from EU-PEARL (2024) Nguyen QL, Hees K, Hernandez Penna S, König F, Posch M, Bofill Roig M, Meyer EL, et al. Journal article, Review article Challenging a paradigm: Skin sensitivity to sodium lauryl sulfate is independent of atopic diathesis (2023) Heetfeld A, Schill T, Schroeder S, Forkel S, Mahler V, Pfuetzner W, Schoen MP, et al. Conference contribution Adaptive platform trials: the impact of common controls on type one error and power (2023) Nguyen Q, Hees K, Hofner B Journal article